• Baek, S.H., Ko, J.H., Lee, J.H., Kim, C., Lee, H., Nam, D., Lee, J., Lee, S.G., Yang, W.M., Um, J.Y., Sethi, G., Ahn, K.S., 2017. Ginkgolic acid inhibits invasion and migration and TGF-beta-induced EMT of lung cancer cells through PI3K/Akt/mTOR inactivation. J. Cell. Physiol. 232, 346–354.

  • Bahrami, B.F., Ataie-Kachoie, P., Pourgholami, M.H., Morris, D.L., 2014. p70 Ribosomal protein S6 kinase (Rps6kb1): an update. J. Clin. Pathol. 67, 1019–1025.

  • Bentz, G.L., Shackelford, J., Pagano, J.S., 2012. Epstein-Barr virus latent membrane protein 1 regulates the function of interferon regulatory factor 7 by inducing its sumoylation. J. Virol. 86, 12251–12261.

  • Bruce, J.P., To, K.F., Lui, V.W.Y., Chung, G.T.Y., Chan, Y.Y., Tsang, C.M., Yip, K.Y., Ma, B.B.Y., Woo, J.K.S., Hui, E.P., Mak, M.K.F., Lee, S.D., Chow, C., Velapasamy, S., Or, Y.Y.Y., Siu, P.K., El Ghamrasni, S., Prokopec, S., Wu, M., Kwan, J.S.H., Liu, Y., Chan, J.Y.K., van Hasselt, C.A., Young, L.S., Dawson, C.W., Paterson, I.C., Yap, L.F., Tsao, S.W., Liu, F.F., Chan, A.T.C., Pugh, T.J., Lo, K.W., 2021. Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-kappaB activation and immune escape. Nat. Commun. 12, 4193.

  • Bruce, J.P., Yip, K., Bratman, S.V., Ito, E., Liu, F.F., 2015. Nasopharyngeal cancer:molecular landscape. J. Clin. Oncol. 33, 3346–3355.

  • Carnero, A., Blanco-Aparicio, C., Renner, O., Link, W., Leal, J.F., 2008. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr. Cancer Drug Targets 8, 187–198.

  • Cheung, S.T., Huang, D.P., Hui, A.B., Lo, K.W., Ko, C.W., Tsang, Y.S., Wong, N., Whitney, B.M., Lee, J.C., 1999. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int. J. Cancer 83, 121–126.

  • Chu, M.Y., Huang, H.C., Li, E.M., Xu, L.Y., 2021. CypA: a potential target of tumor radiotherapy and/or chemotherapy. Curr. Med. Chem. 28, 3787–3802.

  • Chung, G.T., Lou, W.P., Chow, C., To, K.F., Choy, K.W., Leung, A.W., Tong, C.Y., Yuen, J.W., Ko, C.W., Yip, T.T., Busson, P., Lo, K.W., 2013. Constitutive activation of distinct NF-kappaB signals in EBV-associated nasopharyngeal carcinoma. J. Pathol. 231, 311–322.

  • Dan, H.C., Cooper, M.J., Cogswell, P.C., Duncan, J.A., Ting, J.P., Baldwin, A.S., 2008. Aktdependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK. Genes Dev. 22, 1490–1500.

  • Dang, W., Cao, P., Yan, Q., Yang, L., Wang, Y., Yang, J., Xin, S., Zhang, J., Li, J., Long, S., Zhang, W., Zhang, S., Lu, J., 2021. IGFBP7-AS1 is a p53-responsive long noncoding RNA downregulated by Epstein-Barr virus that contributes to viral tumorigenesis. Cancer Lett. 523, 135–147.

  • Davra, V., Saleh, T., Geng, K., Kimani, S., Mehta, D., Kasikara, C., Smith, B., Colangelo, N.W., Ciccarelli, B., Li, H., Azzam, E.I., Kalodimos, C.G., Birge, R.B., Kumar, S., 2020. Cyclophilin A inhibitor debio-025 targets crk, reduces metastasis, and induces tumor immunogenicity in breast cancer. Mol. Cancer Res. 18, 1189–1201.

  • Dawar, F.U., Tu, J., Khattak, M.N., Mei, J., Lin, L., 2017. Cyclophilin A: a key factor in virus replication and potential target for anti-viral therapy. Curr. Issues Mol. Biol. 21, 1–20.

  • Delecluse, H.J., Hilsendegen, T., Pich, D., Zeidler, R., Hammerschmidt, W., 1998. Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc. Natl. Acad. Sci. U. S. A. 95, 8245–8250.

  • Gandhi, M.K., Tellam, J.T., Khanna, R., 2004. Epstein-Barr virus-associated Hodgkin's lymphoma. Br. J. Haematol. 125, 267–281.

  • Guo, M., James, A.W., Kwak, J.H., Shen, J., Yokoyama, K.K., Ting, K., Soo, C.B., Chiu, R.H., 2016. Cyclophilin A (CypA) plays dual roles in regulation of bone anabolism and resorption. Sci. Rep. 6, 22378.

  • Gutierrez, A., Look, A.T., 2007. NOTCH and PI3K-AKT pathways intertwined. Cancer Cell 12, 411–413.

  • Huang, S.C.M., Tsao, S.W., Tsang, C.M., 2018. Interplay of viral infection, host cell factors and tumor microenvironment in the pathogenesis of nasopharyngeal carcinoma. Cancers 10, 106.

  • Kang, M.S., Kieff, E., 2015. Epstein-Barr virus latent genes. Exp. Mol. Med. 47, e131.

  • Kim, S.W., Kim, S.M., Bae, H., Nam, D., Lee, J.H., Lee, S.G., Shim, B.S., Kim, S.H., Ahn, K.S., Choi, S.H., Sethi, G., Ahn, K.S., 2013. Embelin inhibits growth and induces apoptosis through the suppression of Akt/mTOR/S6K1 signaling cascades. Prostate 73, 296–305.

  • Lin, D.C., Meng, X., Hazawa, M., Nagata, Y., Varela, A.M., Xu, L., Sato, Y., Liu, L.Z., Ding, L.W., Sharma, A., Goh, B.C., Lee, S.C., Petersson, B.F., Yu, F.G., Macary, P., Oo, M.Z., Ha, C.S., Yang, H., Ogawa, S., Loh, K.S., Koeffler, H.P., 2014. The genomic landscape of nasopharyngeal carcinoma. Nat. Genet. 46, 866–871.

  • Liu, L., Zhou, Q., Xie, Y., Zuo, L., Zhu, F., Lu, J., 2017. Extracellular vesicles: novel vehicles in herpesvirus infection. Virol. Sin. 32, 349–356.

  • Liu, L., Zuo, L., Yang, J., Xin, S., Zhang, J., Zhou, J., Li, G., Tang, J., Lu, J., 2019a. Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein-Barr virus associated nasopharyngeal carcinoma. Cancer Med. 8, 3142–3151.

  • Liu, R., Qu, Z., Lin, Y., Lee, C.S., Tai, W.C., Chen, S., 2019b. Brevilin A induces cell cycle arrest and apoptosis in nasopharyngeal carcinoma. Front. Pharmacol. 10, 594.

  • Lo, K.W., Chung, G.T., To, K.F., 2012. Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. Semin. Cancer Biol. 22, 79–86.

  • Lu, J., Han, Z., Liu, Y., Liu, W., Lee, M.S., Olson, M.A., Ruthel, G., Freedman, B.D., Harty, R.N., 2014. A host-oriented inhibitor of Junin Argentine hemorrhagic fever virus egress. J. Virol. 88, 4736–4743.

  • Lu, J., Qu, Y., Liu, Y., Jambusaria, R., Han, Z., Ruthel, G., Freedman, B.D., Harty, R.N., 2013. Host IQGAP1 and Ebola virus VP40 interactions facilitate virus-like particle egress. J. Virol. 87, 7777–7780.

  • Lu, J.H., Tang, Y.L., Yu, H.B., Zhou, J.H., Fu, C.Y., Zeng, X., Yu, Z.Y., Yin, H.L., Wu, M.H., Zhang, J.Y., Li, X.L., Li, G.Y., 2010. Epstein-Barr virus facilitates the malignant potential of immortalized epithelial cells: from latent genome to viral production and maintenance. Lab. Invest. 90, 196–209.

  • Manning, B.D., Cantley, L.C., 2007. AKT/PKB signaling: navigating downstream. Cell 129, 1261–1274.

  • Manning, B.D., Toker, A., 2017. AKT/PKB signaling: navigating the network. Cell 169, 381–405.

  • Mohan, C.D., Srinivasa, V., Rangappa, S., Mervin, L., Mohan, S., Paricharak, S., Baday, S., Li, F., Shanmugam, M.K., Chinnathambi, A., Zayed, M.E., Alharbi, S.A., Bender, A., Sethi, G., Basappa, Rangappa, K.S., 2016. Trisubstituted-imidazoles induce apoptosis in human breast cancer cells by targeting the oncogenic PI3K/Akt/mTOR signaling pathway. PLoS One 11, e0153155.

  • Nakanishi, Y., Wakisaka, N., Kondo, S., Endo, K., Sugimoto, H., Hatano, M., Ueno, T., Ishikawa, K., Yoshizaki, T., 2017. Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma. Cancer Metastasis Rev. 36, 435–447.

  • Nigro, P., Pompilio, G., Capogrossi, M.C., 2013. Cyclophilin A: a key player for human disease. Cell Death Dis. 4, e888.

  • Nishikawa, J., Iizasa, H., Yoshiyama, H., Shimokuri, K., Kobayashi, Y., Sasaki, S., Nakamura, M., Yanai, H., Sakai, K., Suehiro, Y., Yamasaki, T., Sakaida, I., 2018. Clinical importance of Epstein(-)Barr virus-associated gastric cancer. Cancers (Basel) 10, 167.

  • Polivka Jr., J., Janku, F., 2014. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol. Ther. 142, 164–175.

  • Qin, L., Li, X., Lin, Z., Li, H., Mo, Y., Su, F., Mo, W., Yang, Z., 2017. EBV-LMP1 regulating AKT/mTOR signaling pathway and WWOX in nasopharyngeal carcinoma. Int. J. Clin. Exp. Pathol. 10, 8619–8625.

  • Shair, K.H.Y., Reddy, A., Cooper, V.S., 2018. New insights from elucidating the role of LMP1 in nasopharyngeal carcinoma. Cancers (Basel) 10, 86.

  • Shih, Y.L., Chou, H.M., Chou, H.C., Lu, H.F., Chu, Y.L., Shang, H.S., Chung, J.G., 2017. Casticin impairs cell migration and invasion of mouse melanoma B16F10 cells via PI3K/AKT and NF-kappaB signaling pathways. Environ. Toxicol. 32, 2097–2112.

  • Siveen, K.S., Ahn, K.S., Ong, T.H., Shanmugam, M.K., Li, F., Yap, W.N., Kumar, A.P., Fong, C.W., Tergaonkar, V., Hui, K.M., Sethi, G., 2014. Y-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model. Oncotarget 5, 1897–1911.

  • Strickland, S.W., Vande Pol, S., 2016. The human papillomavirus 16 E7 oncoprotein attenuates AKT signaling to promote internal ribosome entry site-dependent translation and expression of c-MYC. J. Virol. 90, 5611–5621.

  • Takada, H., Imadome, K.I., Shibayama, H., Yoshimori, M., Wang, L., Saitoh, Y., Uota, S., Yamaoka, S., Koyama, T., Shimizu, N., Yamamoto, K., Fujiwara, S., Miura, O., Arai, A., 2017. EBV induces persistent NF-kappaB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells. PLoS One 12, e0174136.

  • Toker, A., Dibble, C.C., 2018. PI 3-kinase signaling: AKTing up inside the cell. Mol. Cell 71, 875–876.

  • Tu, C., Zeng, Z., Qi, P., Li, X., Guo, C., Xiong, F., Xiang, B., Zhou, M., Liao, Q., Yu, J., Li, Y., Li, X., Li, G., Xiong, W., 2018. Identification of genomic alterations in nasopharyngeal carcinoma and nasopharyngeal carcinoma-derived Epstein-Barr virus by wholegenome sequencing. Carcinogenesis 39, 1517–1528.

  • Wang, G., Shen, J., Sun, J., Jiang, Z., Fan, J., Wang, H., Yu, S., Long, Y., Liu, Y., Bao, H., Zhang, K.X., Han, K., Zhu, M., Zheng, Y., Lin, Z., Jiang, C., Guo, M., 2017. Cyclophilin A maintains glioma-initiating cell stemness by regulating wnt/beta-catenin signaling. Clin. Cancer Res. 23, 6640–6649.

  • West, R.B., 2014. Fingerprints of Epstein-Barr virus in nasopharyngeal carcinoma. Nat. Genet. 46, 809–810.

  • Wu, C.C., Fang, C.Y., Huang, S.Y., Chiu, S.H., Lee, C.H., Chen, J.Y., 2018. Perspective:contribution of epstein-barr virus (EBV) reactivation to the carcinogenicity of nasopharyngeal cancer cells. Cancers (Basel) 10, 120.

  • Xin, S., Du, S., Liu, L., Xie, Y., Zuo, L., Yang, J., Hu, J., Yue, W., Zhang, J., Cao, P., Zhu, F., Lu, J., 2019. Epstein-barr virus nuclear antigen 1 recruits cyclophilin A to facilitate the replication of viral DNA genome. Front. Microbiol. 10, 2879.

  • Yamamoto, T., Takakura, H., Mitamura, K., Taga, A., 2020. Cyclophilin a knokdown inhibits cell migration and invasion through the suppression of epithelial-mesenchymal transition in colorectal cancer cells. Biochem. Biophys. Res. Commun. 526, 55–61.

  • Yang, J., Zhou, M., Zhao, R., Peng, S., Luo, Z., Li, X., Cao, L., Tang, K., Ma, J., Xiong, W., Fan, S., Schmitt, D.C., Tan, M., Li, X., Li, G., 2014. Identification of candidate biomarkers for the early detection of nasopharyngeal carcinoma by quantitative proteomic analysis. J. Proteonomics 109, 162–175.

  • Yi, M., Cai, J., Li, J., Chen, S., Zeng, Z., Peng, Q., Ban, Y., Zhou, Y., Li, X., Xiong, W., Li, G., Xiang, B., 2018. Rediscovery of NF-kappaB signaling in nasopharyngeal carcinoma:how genetic defects of NF-kappaB pathway interplay with EBV in driving oncogenesis? J. Cell. Physiol. 233, 5537–5549.

  • Yin, Y., Dang, W., Zhou, X., Xu, L., Wang, W., Cao, W., Chen, S., Su, J., Cai, X., Xiao, S., Peppelenbosch, M.P., Pan, Q., 2018. PI3K-Akt-mTOR axis sustains rotavirus infection via the 4E-BP1 mediated autophagy pathway and represents an antiviral target. Virulence 9, 83–98.

  • Yu, J.S., Cui, W., 2016. Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination. Development 143, 3050–3060.

  • Yuan, Y., Hou, X., Feng, H., Liu, R., Xu, H., Gong, W., Deng, J., Sun, C., Gao, Y., Peng, J., Wu, Y., Li, J., Fang, C., Chen, Q., 2016. Proteomic identification of cyclophilin A as a potential biomarker and therapeutic target in oral submucous fibrosis. Oncotarget 7, 60348–60365.

  • Zhu, D., Wang, Z., Zhao, J.J., Calimeri, T., Meng, J., Hideshima, T., Fulciniti, M., Kang, Y., Ficarro, S.B., Tai, Y.T., Hunter, Z., McMilin, D., Tong, H., Mitsiades, C.S., Wu, C.J., Treon, S.P., Dorfman, D.M., Pinkus, G., Munshi, N.C., Tassone, P., Marto, J.A., Anderson, K.C., Carrasco, R.D., 2015. The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells. Nat. Med. 21, 572–580.

  • Zuo, L., Xie, Y., Tang, J., Xin, S., Liu, L., Zhang, S., Yan, Q., Zhu, F., Lu, J., 2019. Targeting exosomal EBV-LMP1 transfer and miR-203 expression via the NF-kappaB pathway:the therapeutic role of aspirin in NPC. Mol. Ther. Nucleic Acids 17, 175–184.

  • Zuo, L., Yu, H., Liu, L., Tang, Y., Wu, H., Yang, J., Zhu, M., Du, S., Zhao, L., Cao, L., Li, G., Lu, J., 2015. The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-kappaB. Oncotarget 6, 41033–41044.